Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Prepaid Assets (2016 - 2025)

China Pharma Holdings filings provide 12 years of Prepaid Assets readings, the most recent being $82368.0 for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 1.28% to $82368.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $82368.0, a 1.28% increase, with the full-year FY2025 number at $82368.0, up 1.28% from a year prior.
  • Prepaid Assets hit $82368.0 in Q4 2025 for China Pharma Holdings, up from $75627.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $268498.0 in Q3 2023 to a low of $54034.0 in Q2 2021.
  • Median Prepaid Assets over the past 5 years was $82418.5 (2025), compared with a mean of $100536.0.
  • Biggest five-year swings in Prepaid Assets: tumbled 86.4% in 2021 and later skyrocketed 207.67% in 2023.
  • China Pharma Holdings' Prepaid Assets stood at $58792.0 in 2021, then soared by 32.16% to $77697.0 in 2022, then soared by 41.91% to $110258.0 in 2023, then decreased by 26.24% to $81328.0 in 2024, then grew by 1.28% to $82368.0 in 2025.
  • The last three reported values for Prepaid Assets were $82368.0 (Q4 2025), $75627.0 (Q3 2025), and $74869.0 (Q2 2025) per Business Quant data.